Contract Development & Manufacturing Organization (CDMO) Market Size, Share & Industry Analysis, By Service (Contract Manufacturing {API Manufacturing, Finished Product [Solid Dosage Forms, Injectables, and Others], and Packaging}, and Contract Development {Formulation Development, Process Development & Scale-up, Analytical Method Development & Validation, Stability Testing, CMC & Regulatory Development Support, and Others}), By Molecule Type, By Therapeutic Area (Oncology, Infectious Diseases, Neurology, Cardiology, Metabolic Disorders, and Others) and Regional Forecast, 2026-2034

Last Updated: July 20, 2026 | Format: PDF | Report ID: FBI102502

Buy Now

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Challenges
5. Market Trends
Key Insights
1. Advancements in Contract Development & Manufacturing Organization (CDMO)
2. Overview of Regulatory Scenario, By Key Countries/Regions
3. Key Industry Developments – (Mergers, Acquisitions, & Partnerships, etc.)
Global Contract Development & Manufacturing Organization (CDMO) Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Service
  1. Contract Manufacturing
    1. API Manufacturing
    2. Finished Product
      1. Solid Dosage Forms
      2. Injectables
      3. Others
    3. Packaging
  2. Contract Development
    1. Formulation Development
    2. Process Development & Scale-up
    3. Analytical Method Development & Validation
    4. Stability Testing
    5. CMC & Regulatory Development Support
    6. Others
2. Market Analysis, Insights and Forecast – By Molecule Type
  1. Small Molecules
  2. Biologics
  3. Cell & Gene Therapies
  4. Others
3. Market Analysis, Insights and Forecast – By Therapeutic Area
  1. Oncology
  2. Infectious Diseases
  3. Neurology
  4. Cardiology
  5. Immunology & Inflammation
  6. Metabolic Disorders
  7. Others
4. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Rest of the World
North America Contract Development & Manufacturing Organization (CDMO) Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Service
  1. Contract Manufacturing
    1. API Manufacturing
    2. Finished Product
      1. Solid Dosage Forms
      2. Injectables
      3. Others
    3. Packaging
  2. Contract Development
    1. Formulation Development
    2. Process Development & Scale-up
    3. Analytical Method Development & Validation
    4. Stability Testing
    5. CMC & Regulatory Development Support
    6. Others
2. Market Analysis, Insights and Forecast – By Molecule Type
  1. Small Molecules
  2. Biologics
  3. Cell & Gene Therapies
  4. Others
3. Market Analysis, Insights and Forecast – By Therapeutic Area
  1. Oncology
  2. Infectious Diseases
  3. Neurology
  4. Cardiology
  5. Immunology & Inflammation
  6. Metabolic Disorders
  7. Others
4. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Contract Development & Manufacturing Organization (CDMO) Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Service
  1. Contract Manufacturing
    1. API Manufacturing
    2. Finished Product
      1. Solid Dosage Forms
      2. Injectables
      3. Others
    3. Packaging
  2. Contract Development
    1. Formulation Development
    2. Process Development & Scale-up
    3. Analytical Method Development & Validation
    4. Stability Testing
    5. CMC & Regulatory Development Support
    6. Others
2. Market Analysis, Insights and Forecast – By Molecule Type
  1. Small Molecules
  2. Biologics
  3. Cell & Gene Therapies
  4. Others
3. Market Analysis, Insights and Forecast – By Therapeutic Area
  1. Oncology
  2. Infectious Diseases
  3. Neurology
  4. Cardiology
  5. Immunology & Inflammation
  6. Metabolic Disorders
  7. Others
4. Market Analysis, Insights and Forecast – By Countries/Sub-region
  1. Germany
  2. France
  3. U.K.
  4. Italy
  5. Spain
  6. Scandinavia
  7. Rest of the Europe
Asia Pacific Contract Development & Manufacturing Organization (CDMO) Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Service
  1. Contract Manufacturing
    1. API Manufacturing
    2. Finished Product
      1. Solid Dosage Forms
      2. Injectables
      3. Others
    3. Packaging
  2. Contract Development
    1. Formulation Development
    2. Process Development & Scale-up
    3. Analytical Method Development & Validation
    4. Stability Testing
    5. CMC & Regulatory Development Support
    6. Others
2. Market Analysis, Insights and Forecast – By Molecule Type
  1. Small Molecules
  2. Biologics
  3. Cell & Gene Therapies
  4. Others
3. Market Analysis, Insights and Forecast – By Therapeutic Area
  1. Oncology
  2. Infectious Diseases
  3. Neurology
  4. Cardiology
  5. Immunology & Inflammation
  6. Metabolic Disorders
  7. Others
4. Market Analysis, Insights and Forecast – By Countries/Sub-region
  1. China
  2. Japan
  3. India
  4. Australia & New Zealand
  5. Rest of Asia Pacific
Rest of the World Contract Development & Manufacturing Organization (CDMO) Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Service
  1. Contract Manufacturing
    1. API Manufacturing
    2. Finished Product
      1. Solid Dosage Forms
      2. Injectables
      3. Others
    3. Packaging
  2. Contract Development
    1. Formulation Development
    2. Process Development & Scale-up
    3. Analytical Method Development & Validation
    4. Stability Testing
    5. CMC & Regulatory Development Support
    6. Others
2. Market Analysis, Insights and Forecast – By Molecule Type
  1. Small Molecules
  2. Biologics
  3. Cell & Gene Therapies
  4. Others
3. Market Analysis, Insights and Forecast – By Therapeutic Area
  1. Oncology
  2. Infectious Diseases
  3. Neurology
  4. Cardiology
  5. Immunology & Inflammation
  6. Metabolic Disorders
  7. Others
Competitive Analysis
1. Global Market Share Analysis (2024)
2. Company Profiles (Overview, Services, SWOT analysis, Recent developments, strategies, financials (based on availability))
  1. Lonza
  2. Thermo Fisher Scientific Inc.
  3. Catalent, Inc
  4. Samsung Biologics
  5. WuXi Biologics
  6. Siegfried Holding AG
  7. FUJIFILM Holdings Corporation
  8. Boehringer Ingelheim International GmbH
  9. Recipharm AB
  10. Cambrex Corporation

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Challenges
5. Market Trends
Key Insights
1. Advancements in Contract Development & Manufacturing Organization (CDMO)
2. Overview of Regulatory Scenario, By Key Countries/Regions
3. Key Industry Developments – (Mergers, Acquisitions, & Partnerships, etc.)
Global Contract Development & Manufacturing Organization (CDMO) Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Service
  1. Contract Manufacturing
    1. API Manufacturing
    2. Finished Product
      1. Solid Dosage Forms
      2. Injectables
      3. Others
    3. Packaging
  2. Contract Development
    1. Formulation Development
    2. Process Development & Scale-up
    3. Analytical Method Development & Validation
    4. Stability Testing
    5. CMC & Regulatory Development Support
    6. Others
2. Market Analysis, Insights and Forecast – By Molecule Type
  1. Small Molecules
  2. Biologics
  3. Cell & Gene Therapies
  4. Others
3. Market Analysis, Insights and Forecast – By Therapeutic Area
  1. Oncology
  2. Infectious Diseases
  3. Neurology
  4. Cardiology
  5. Immunology & Inflammation
  6. Metabolic Disorders
  7. Others
4. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Rest of the World
North America Contract Development & Manufacturing Organization (CDMO) Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Service
  1. Contract Manufacturing
    1. API Manufacturing
    2. Finished Product
      1. Solid Dosage Forms
      2. Injectables
      3. Others
    3. Packaging
  2. Contract Development
    1. Formulation Development
    2. Process Development & Scale-up
    3. Analytical Method Development & Validation
    4. Stability Testing
    5. CMC & Regulatory Development Support
    6. Others
2. Market Analysis, Insights and Forecast – By Molecule Type
  1. Small Molecules
  2. Biologics
  3. Cell & Gene Therapies
  4. Others
3. Market Analysis, Insights and Forecast – By Therapeutic Area
  1. Oncology
  2. Infectious Diseases
  3. Neurology
  4. Cardiology
  5. Immunology & Inflammation
  6. Metabolic Disorders
  7. Others
4. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Contract Development & Manufacturing Organization (CDMO) Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Service
  1. Contract Manufacturing
    1. API Manufacturing
    2. Finished Product
      1. Solid Dosage Forms
      2. Injectables
      3. Others
    3. Packaging
  2. Contract Development
    1. Formulation Development
    2. Process Development & Scale-up
    3. Analytical Method Development & Validation
    4. Stability Testing
    5. CMC & Regulatory Development Support
    6. Others
2. Market Analysis, Insights and Forecast – By Molecule Type
  1. Small Molecules
  2. Biologics
  3. Cell & Gene Therapies
  4. Others
3. Market Analysis, Insights and Forecast – By Therapeutic Area
  1. Oncology
  2. Infectious Diseases
  3. Neurology
  4. Cardiology
  5. Immunology & Inflammation
  6. Metabolic Disorders
  7. Others
4. Market Analysis, Insights and Forecast – By Countries/Sub-region
  1. Germany
  2. France
  3. U.K.
  4. Italy
  5. Spain
  6. Scandinavia
  7. Rest of the Europe
Asia Pacific Contract Development & Manufacturing Organization (CDMO) Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Service
  1. Contract Manufacturing
    1. API Manufacturing
    2. Finished Product
      1. Solid Dosage Forms
      2. Injectables
      3. Others
    3. Packaging
  2. Contract Development
    1. Formulation Development
    2. Process Development & Scale-up
    3. Analytical Method Development & Validation
    4. Stability Testing
    5. CMC & Regulatory Development Support
    6. Others
2. Market Analysis, Insights and Forecast – By Molecule Type
  1. Small Molecules
  2. Biologics
  3. Cell & Gene Therapies
  4. Others
3. Market Analysis, Insights and Forecast – By Therapeutic Area
  1. Oncology
  2. Infectious Diseases
  3. Neurology
  4. Cardiology
  5. Immunology & Inflammation
  6. Metabolic Disorders
  7. Others
4. Market Analysis, Insights and Forecast – By Countries/Sub-region
  1. China
  2. Japan
  3. India
  4. Australia & New Zealand
  5. Rest of Asia Pacific
Rest of the World Contract Development & Manufacturing Organization (CDMO) Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Service
  1. Contract Manufacturing
    1. API Manufacturing
    2. Finished Product
      1. Solid Dosage Forms
      2. Injectables
      3. Others
    3. Packaging
  2. Contract Development
    1. Formulation Development
    2. Process Development & Scale-up
    3. Analytical Method Development & Validation
    4. Stability Testing
    5. CMC & Regulatory Development Support
    6. Others
2. Market Analysis, Insights and Forecast – By Molecule Type
  1. Small Molecules
  2. Biologics
  3. Cell & Gene Therapies
  4. Others
3. Market Analysis, Insights and Forecast – By Therapeutic Area
  1. Oncology
  2. Infectious Diseases
  3. Neurology
  4. Cardiology
  5. Immunology & Inflammation
  6. Metabolic Disorders
  7. Others
Competitive Analysis
1. Global Market Share Analysis (2024)
2. Company Profiles (Overview, Services, SWOT analysis, Recent developments, strategies, financials (based on availability))
  1. Lonza
  2. Thermo Fisher Scientific Inc.
  3. Catalent, Inc
  4. Samsung Biologics
  5. WuXi Biologics
  6. Siegfried Holding AG
  7. FUJIFILM Holdings Corporation
  8. Boehringer Ingelheim International GmbH
  9. Recipharm AB
  10. Cambrex Corporation

Read Less

List of Figures

Figure 1: Global Contract Development & Manufacturing Organization (CDMO) Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034

Figure 2: Global Contract Development & Manufacturing Organization (CDMO) Market Value Share (%), by Service, 2025 & 2034

Figure 3: Global Contract Development & Manufacturing Organization (CDMO) Market Value Share (%), by Molecule Type, 2025 & 2034

Figure 4: Global Contract Development & Manufacturing Organization (CDMO) Market Value Share (%), by Therapeutic Area, 2025 & 2034

Figure 5: Global Contract Development & Manufacturing Organization (CDMO) Market Value (USD billion), by Region, 2025 & 2034

Figure 6: North America Contract Development & Manufacturing Organization (CDMO) Market Value (USD billion), by Service, 2025 & 2034

Figure 7: North America Contract Development & Manufacturing Organization (CDMO) Market Value Share (%), by Service, 2025

Figure 8: North America Contract Development & Manufacturing Organization (CDMO) Market Value (USD billion), by Molecule Type, 2025 & 2034

Figure 9: North America Contract Development & Manufacturing Organization (CDMO) Market Value Share (%), by Molecule Type, 2025

Figure 10: North America Contract Development & Manufacturing Organization (CDMO) Market Value (USD billion), by Therapeutic Area, 2025 & 2034

Figure 11: North America Contract Development & Manufacturing Organization (CDMO) Market Value Share (%), by Therapeutic Area, 2026

Figure 12: North America Contract Development & Manufacturing Organization (CDMO) Market Value (USD billion), By Country, 2025 & 2034

Figure 13: North America Contract Development & Manufacturing Organization (CDMO) Market Value Share (%), By Country, 2025

Figure 14: Europe Contract Development & Manufacturing Organization (CDMO) Market Value (USD billion), by Service, 2025 & 2034

Figure 15: Europe Contract Development & Manufacturing Organization (CDMO) Market Value Share (%), by Service, 2025

Figure 16: Europe Contract Development & Manufacturing Organization (CDMO) Market Value (USD billion), by Molecule Type, 2025 & 2034

Figure 17: Europe Contract Development & Manufacturing Organization (CDMO) Market Value Share (%), by Molecule Type, 2025

Figure 18: Europe Contract Development & Manufacturing Organization (CDMO) Market Value (USD billion), by Therapeutic Area, 2025 & 2034

Figure 19: Europe Contract Development & Manufacturing Organization (CDMO) Market Value Share (%), by Therapeutic Area, 2026

Figure 20: Europe Contract Development & Manufacturing Organization (CDMO) Market Value (USD billion), By Country/Sub-region, 2025 & 2034

Figure 21: Europe Contract Development & Manufacturing Organization (CDMO) Market Value Share (%), By Country/Sub-region, 2025

Figure 22: Asia Pacific Contract Development & Manufacturing Organization (CDMO) Market Value (USD billion), by Service, 2025 & 2034

Figure 23: Asia Pacific Contract Development & Manufacturing Organization (CDMO) Market Value Share (%), by Service, 2025

Figure 24: Asia Pacific Contract Development & Manufacturing Organization (CDMO) Market Value (USD billion), by Molecule Type, 2025 & 2034

Figure 25: Asia Pacific Contract Development & Manufacturing Organization (CDMO) Market Value Share (%), by Molecule Type, 2025

Figure 26: Asia Pacific Contract Development & Manufacturing Organization (CDMO) Market Value (USD billion), by Therapeutic Area, 2025 & 2034

Figure 27: Asia Pacific Contract Development & Manufacturing Organization (CDMO) Market Value Share (%), by Therapeutic Area, 2026

Figure 28: Asia Pacific Contract Development & Manufacturing Organization (CDMO) Market Value (USD billion), By Country/Sub-region, 2025 & 2034

Figure 29: Asia Pacific Contract Development & Manufacturing Organization (CDMO) Market Value Share (%), By Country/Sub-region, 2025

Figure 30: Rest of the World Contract Development & Manufacturing Organization (CDMO) Market Value (USD billion), by Service, 2025 & 2034

Figure 31: Rest of the World Contract Development & Manufacturing Organization (CDMO) Market Value Share (%), by Service, 2025

Figure 32: Rest of the World Contract Development & Manufacturing Organization (CDMO) Market Value (USD billion), by Molecule Type, 2025 & 2034

Figure 33: Rest of the World Contract Development & Manufacturing Organization (CDMO) Market Value Share (%), by Molecule Type, 2025

Figure 34: Rest of the World Contract Development & Manufacturing Organization (CDMO) Market Value (USD billion), by Therapeutic Area, 2025 & 2034

Figure 35: Rest of the World Contract Development & Manufacturing Organization (CDMO) Market Value Share (%), by Therapeutic Area, 2026

Figure 36: Global Contract Development & Manufacturing Organization (CDMO) Market Share (%), By Company, 2025

List of Tables

Table 1: Global Contract Development & Manufacturing Organization (CDMO) Market Revenue (USD billion) Forecast, by Service, 2021–2034

Table 2: Global Contract Development & Manufacturing Organization (CDMO) Market Revenue (USD billion) Forecast, by Contract Manufacturing, 2021–2034

Table 3: Global Contract Development & Manufacturing Organization (CDMO) Market Revenue (USD billion) Forecast, by Finished Product, 2021–2034

Table 4: Global Contract Development & Manufacturing Organization (CDMO) Market Revenue (USD billion) Forecast, by Contract Development, 2021–2034

Table 5: Global Contract Development & Manufacturing Organization (CDMO) Market Revenue (USD billion) Forecast, by Molecule Type, 2021–2034

Table 6: Global Contract Development & Manufacturing Organization (CDMO) Market Revenue (USD billion) Forecast, by Therapeutic Area, 2021–2034

Table 7: Global Contract Development & Manufacturing Organization (CDMO) Market Revenue (USD billion) Forecast, by Region, 2021-2034

Table 8: North America Contract Development & Manufacturing Organization (CDMO) Market Revenue (USD billion) Forecast, by Service, 2021–2034

Table 9: North America Contract Development & Manufacturing Organization (CDMO) Market Revenue (USD billion) Forecast, by Contract Manufacturing, 2021–2034

Table 10: North America Contract Development & Manufacturing Organization (CDMO) Market Revenue (USD billion) Forecast, by Finished Product, 2021–2034

Table 11: North America Contract Development & Manufacturing Organization (CDMO) Market Revenue (USD billion) Forecast, by Contract Development, 2021–2034

Table 12: North America Contract Development & Manufacturing Organization (CDMO) Market Revenue (USD billion) Forecast, by Molecule Type, 2021–2034

Table 13: North America Contract Development & Manufacturing Organization (CDMO) Market Revenue (USD billion) Forecast, by Therapeutic Area, 2021–2034

Table 14: North America Contract Development & Manufacturing Organization (CDMO) Market Revenue (USD billion) Forecast, by Country, 2021-2034

Table 15: Europe Contract Development & Manufacturing Organization (CDMO) Market Revenue (USD billion) Forecast, by Service, 2021–2034

Table 16: Europe Contract Development & Manufacturing Organization (CDMO) Market Revenue (USD billion) Forecast, by Contract Manufacturing, 2021–2034

Table 17: Europe Contract Development & Manufacturing Organization (CDMO) Market Revenue (USD billion) Forecast, by Finished Product, 2021–2034

Table 18: Europe Contract Development & Manufacturing Organization (CDMO) Market Revenue (USD billion) Forecast, by Contract Development, 2021–2034

Table 19: Europe Contract Development & Manufacturing Organization (CDMO) Market Revenue (USD billion) Forecast, by Molecule Type, 2021–2034

Table 20: Europe Contract Development & Manufacturing Organization (CDMO) Market Revenue (USD billion) Forecast, by Therapeutic Area, 2021–2034

Table 21: Europe Contract Development & Manufacturing Organization (CDMO) Market Revenue (USD billion) Forecast, by Country/Sub-region, 2021-2034

Table 22: Asia Pacific Contract Development & Manufacturing Organization (CDMO) Market Revenue (USD billion) Forecast, by Service, 2021–2034

Table 23: Asia Pacific Contract Development & Manufacturing Organization (CDMO) Market Revenue (USD billion) Forecast, by Contract Manufacturing, 2021–2034

Table 24: Asia Pacific Contract Development & Manufacturing Organization (CDMO) Market Revenue (USD billion) Forecast, by Finished Product, 2021–2034

Table 25: Asia Pacific Contract Development & Manufacturing Organization (CDMO) Market Revenue (USD billion) Forecast, by Contract Development, 2021–2034

Table 26: Asia Pacific Contract Development & Manufacturing Organization (CDMO) Market Revenue (USD billion) Forecast, by Molecule Type, 2021–2034

Table 27: Asia Pacific Contract Development & Manufacturing Organization (CDMO) Market Revenue (USD billion) Forecast, by Therapeutic Area, 2021–2034

Table 28: Asia Pacific Contract Development & Manufacturing Organization (CDMO) Market Revenue (USD billion) Forecast, by Country/Sub-region, 2021-2034

Table 29: Rest of the World Contract Development & Manufacturing Organization (CDMO) Market Revenue (USD billion) Forecast, by Service, 2021–2034

Table 30: Rest of the World Contract Development & Manufacturing Organization (CDMO) Market Revenue (USD billion) Forecast, by Contract Manufacturing, 2021–2034

Table 31: Rest of the World Contract Development & Manufacturing Organization (CDMO) Market Revenue (USD billion) Forecast, by Finished Product, 2021–2034

Table 32: Rest of the World Contract Development & Manufacturing Organization (CDMO) Market Revenue (USD billion) Forecast, by Contract Development, 2021–2034

Table 33: Rest of the World Contract Development & Manufacturing Organization (CDMO) Market Revenue (USD billion) Forecast, by Molecule Type, 2021–2034

Table 34: Rest of the World Contract Development & Manufacturing Organization (CDMO) Market Revenue (USD billion) Forecast, by Therapeutic Area, 2021–2034